Medicaid/Medicare

Milliman Medicare Part D Rx Pricing Report

On November 4, 2016, Milliman, Inc. released a report examining the Medicare Part D program and how list prices and rebates for medications impact costs borne by patients, plans, pharmaceutical manufacturers, and the federal government.

View the full report here.

Obama's Actions Could Put HIV Patients at Risk

March 7, 2014

Roll Call

"The Obama administration has done much to improve the health and well-being of many Americans, including people with HIV and AIDS, but we believe they are not currently implementing the law that Congress passed and prioritizing the interests of patients as they should be."

Syndicate content